Loss of anchorage in checkpoint-deficient cells increases genomic instability and promotes oncogenic transformation

Mammalian cells generally require both mitogens and anchorage signals in order to proliferate. An important characteristic of many tumour cells is that they have lost this anchorage-dependent cell-cycle checkpoint, allowing them to proliferate without signals provided by their normal microenvironment. In the absence of anchorage signals from the extracellular matrix, many cell types arrest cell-cycle progression in G1 phase as a result of Rb-dependent checkpoints. However, despite inactivation of p53 and Rb proteins, SV40LT-expressing cells retain anchorage dependency, suggesting the presence of an uncharacterised cell-cycle checkpoint, which can be overridden by coexpression of oncogenic Ras. We report here that, although cyclin-CDK complexes persisted in suspension, proliferation was inhibited in LT-expressing cells by the CDK inhibitor p27Kip1 (p27). Interestingly, this did not induce a stable arrest, but aberrant cell-cycle progression associated with stalled DNA replication, rereplication and chromosomal instability, which was sufficient to increase the frequency of oncogenic transformation. These results firstly indicate loss of anchorage in Rb- and p53-deficient cells as a novel mechanism for promotion of genomic instability; secondly suggest that anchorage checkpoints that protect normal cells from inappropriate proliferation act deleteriously in Rb- and p53-deficient cells to promote tumourigenesis; and thirdly indicate caution in the use of CDK inhibitors for cancer treatment.

[1]  J. Julian Blow,et al.  Replication licensing and cancer — a fatal entanglement? , 2008, Nature Reviews Cancer.

[2]  R. Assoian,et al.  Growth control by intracellular tension and extracellular stiffness. , 2008, Trends in cell biology.

[3]  Ludger Hengst,et al.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy , 2008, Nature Reviews Cancer.

[4]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[5]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[6]  James R Bischoff,et al.  CDK inhibitors in cancer therapy: what is next? , 2008, Trends in pharmacological sciences.

[7]  A. Porter Preventing DNA over-replication: a Cdk perspective , 2008, Cell Division.

[8]  B. Aronow,et al.  Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function , 2007, Oncogene.

[9]  E. Knudsen,et al.  RB Loss Promotes Aberrant Ploidy by Deregulating Levels and Activity of DNA Replication Factors* , 2007, Journal of Biological Chemistry.

[10]  S. Henderson,et al.  Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production , 2007, Proceedings of the National Academy of Sciences.

[11]  Richard W. Kriwacki,et al.  Cdk-Inhibitory Activity and Stability of p27 Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases , 2007, Cell.

[12]  Aaron Bensimon,et al.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.

[13]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[14]  J. Bartek,et al.  Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis. , 2006, Cancer research.

[15]  K. Pumiglia,et al.  Focal Adhesion Kinase Controls Cellular Levels of p27/Kip1 and p21/Cip1 through Skp2-Dependent and -Independent Mechanisms , 2006, Molecular and Cellular Biology.

[16]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[17]  Jiri Bartek,et al.  ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks , 2006, Nature Cell Biology.

[18]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[19]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[20]  W. D. Cress,et al.  Efficient Down-Regulation of Cyclin A-Associated Activity and Expression in Suspended Primary Keratinocytes Requires p21Cip111This work was supported by the Cortner-Couch Endowed Chair for Cancer Research (W. J. P.) and NIH Grants CA73780 (W. J. P.) and CA90489 (W. D. C.) , 2004 .

[21]  W. D. Cress,et al.  Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1). , 2004, Molecular cancer research : MCR.

[22]  Anindya Dutta,et al.  A p53-dependent checkpoint pathway prevents rereplication. , 2003, Molecular cell.

[23]  E. Pérez-Nadales,et al.  Dissecting the Contribution of p16INK4A and the Rb Family to the Ras Transformed Phenotype , 2003, Molecular and Cellular Biology.

[24]  E. Harlow,et al.  The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.

[25]  William C Hahn,et al.  Rules for making human tumor cells. , 2002, The New England journal of medicine.

[26]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[27]  M. Schwartz,et al.  Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. , 2001, Journal of cell science.

[28]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[29]  J. Shay,et al.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. , 2001, Genes & development.

[30]  M. Schwartz,et al.  Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. , 2001, Current opinion in genetics & development.

[31]  A. Lloyd,et al.  Lack of Replicative Senescence in Normal Rodent Glia , 2001, Science.

[32]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[33]  S. Sen,et al.  Aneuploidy and cancer , 2000, Current opinion in oncology.

[34]  M. Bottazzi,et al.  α5β1 Integrin Controls Cyclin D1 Expression by Sustaining Mitogen-activated Protein Kinase Activity in Growth Factor-treated Cells , 1999 .

[35]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[36]  M. Bottazzi,et al.  Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. , 1999, Molecular biology of the cell.

[37]  T. Tsuruo,et al.  Up‐regulation of p27Kip1 Correlates Inversely with Anchorage‐independent Growth of Human Cancer Cell Lines , 1998, Japanese journal of cancer research : Gann.

[38]  M. Kawada,et al.  Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway , 1997, Oncogene.

[39]  R. Kerr Ice Rhythms—Core Reveals a Plethora of Climate Cycles , 1996, Science.

[40]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[41]  James M. Roberts,et al.  Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein , 1996, The Journal of cell biology.

[42]  N. Jones,et al.  E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest , 1996, Current Biology.

[43]  T. Hunter,et al.  Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage , 1996, Science.

[44]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[45]  James M. Roberts,et al.  A link between cyclin A expression and adhesion-dependent cell cycle progression. , 1993, Science.

[46]  V. Freedman,et al.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. , 1974, Cell.